Abcellera’s patent involved in its collaboration with Gilead in infectious disease
SOPHIA ANTIPOLIS, France – June 14, 2019: Abcellera’s patent involved in its collaboration with Gilead in infectious disease. AbCellera has announced a partnership with Gilead to discover antibodies for infectious disease. AbCellera will apply its expertise in single-cell screening of natural immune sources to generate rich panels of antibody candidates for evaluation by Gilead. Gilead[…]